tiprankstipranks
Advertisement
Advertisement

NKTR Stock Latest News

Nektar’s rezpegaldesleukin featured in published atopic dermatitis trial
The FlyNektar’s rezpegaldesleukin featured in published atopic dermatitis trial
12d ago
NKTR
Nektar reinstated with a Neutral at JPMorgan
PremiumThe Fly
Nektar reinstated with a Neutral at JPMorgan
16d ago
NKTR
Nektar Therapeutics’ Earnings Call Highlights Rezpeg Momentum
PremiumCompany Announcements
Nektar Therapeutics’ Earnings Call Highlights Rezpeg Momentum
16d ago
NKTR
Nash Reiterates Buy on Nektar, Citing Strong Cash Position and Rezpegaldesleukin Progress; Keeps $153 Price Target Unchanged
PremiumRatings
Nash Reiterates Buy on Nektar, Citing Strong Cash Position and Rezpegaldesleukin Progress; Keeps $153 Price Target Unchanged
20d ago
NKTR
Nektar: Strong Cash Runway and Rezpeg Momentum Support Unchanged $185 Price Target and Buy Rating
PremiumRatings
Nektar: Strong Cash Runway and Rezpeg Momentum Support Unchanged $185 Price Target and Buy Rating
20d ago
NKTR
Nektar Therapeutics Initiated at Buy on Rezpeg’s Advancing Pivotal Programs and Solid Cash Runway
PremiumRatingsNektar Therapeutics Initiated at Buy on Rezpeg’s Advancing Pivotal Programs and Solid Cash Runway
20d ago
NKTR
Nektar reports Q2 EPS ($1.23), consensus ($2.04)
Premium
The Fly
Nektar reports Q2 EPS ($1.23), consensus ($2.04)
21d ago
NKTR
Nektar: Rezpeg’s Advancing Phase 3 Programs and Disease‑Modifying Potential Support Buy/High Risk Rating with Price Target Maintained at $151
Premium
Ratings
Nektar: Rezpeg’s Advancing Phase 3 Programs and Disease‑Modifying Potential Support Buy/High Risk Rating with Price Target Maintained at $151
23d ago
NKTR
NKTR Earnings this Week: How Will it Perform?
PremiumPre-Earnings
NKTR Earnings this Week: How Will it Perform?
26d ago
NKTR
Nektar’s Phase 3 Eczema Trial Moves Forward: What Investors Should Watch
PremiumCompany Announcements
Nektar’s Phase 3 Eczema Trial Moves Forward: What Investors Should Watch
1M ago
NKTR
Keel, Nektar, Infleqtion, Coinbase, Autodesk Trending With Analysts
PremiumWeekend Updates
Keel, Nektar, Infleqtion, Coinbase, Autodesk Trending With Analysts
1M ago
ADSK
COIN
Nektar initiated with a Buy at Canaccord on rezpegaldesleukin potential
PremiumThe Fly
Nektar initiated with a Buy at Canaccord on rezpegaldesleukin potential
2M ago
NKTR
Nektar initiated with a Buy at Canaccord
PremiumThe FlyNektar initiated with a Buy at Canaccord
2M ago
NKTR
Nektar begins Phase 3 program of rezpegaldesleukin in atopic dermatitis
Premium
The Fly
Nektar begins Phase 3 program of rezpegaldesleukin in atopic dermatitis
2M ago
NKTR
Nektar’s Phase 3 Eczema Bet: What Rezpegaldesleukin Could Mean for NKTR Stock
Premium
Company Announcements
Nektar’s Phase 3 Eczema Bet: What Rezpegaldesleukin Could Mean for NKTR Stock
2M ago
NKTR
Canaccord sees potential Apogee buyout as ‘huge win’ for sector
PremiumThe Fly
Canaccord sees potential Apogee buyout as ‘huge win’ for sector
3M ago
ABBV
APGE
Nektar Stockholders Approve Governance and Incentive Plan Changes
PremiumCompany Announcements
Nektar Stockholders Approve Governance and Incentive Plan Changes
3M ago
8K
NKTR
Nektar management to meet with Piper Sandler
PremiumThe Fly
Nektar management to meet with Piper Sandler
3M ago
NKTR
5 Healthcare Stocks Set to Join the Russell 3000
PremiumMarket News
5 Healthcare Stocks Set to Join the Russell 3000
3M ago
QSI
AGEN
3 Best Healthcare Stocks to Buy in May 2026, According to Analysts
PremiumMarket News3 Best Healthcare Stocks to Buy in May 2026, According to Analysts
4M ago
CRNX
LEGN
Nektar price target lowered to $80 from $95 at Wedbush
Premium
The Fly
Nektar price target lowered to $80 from $95 at Wedbush
4M ago
NKTR
Nektar Therapeutics Charts Aggressive Path With REZPEG
Premium
Company Announcements
Nektar Therapeutics Charts Aggressive Path With REZPEG
4M ago
NKTR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >